{
  "id": 2624,
  "text": "417.Petru, E., et al.Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.Eur J Obstet Gynecol Reprod Biol 143, 69-74 (2009).418.Meva, J., et al.Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 417.Petru, E., et al.Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.Eur J Obstet Gynecol Reprod Biol 143, 69-74 (2009).418.Meva, J., et al.Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "当前的FIGO分期系统在治疗宫颈癌时与TNM分类系统相比，确实存在一些不足之处。虽然FIGO分期系统在全球范围内广泛应用，其主要功能是通过临床检查确定癌症的范围和进展。然而，TNM分类能够通过更详细的肿瘤、淋巴结和转移的评估，提供更确切和精确的癌症分期。这意味着在某些情况下，使用TNM分类可能会更有助于制定更个性化的治疗方案。\n\n此外，FIGO分期系统在具体的肿瘤大小及其生物学特征的评价方面也存在局限性。因此，在处理复杂病例时，尤其是需要精确评估淋巴结状态和远处转移的情况下，结合使用TNM分类系统可能更有优势。\n\n综上所述，虽然FIGO分期系统提供了一种方便的临床工具，但对于某些患者而言，TNM分类可能会提供更全面的信息，从而有助于治疗决策和预后评估。",
  "query": "如果以现行FIGO分期系统治疗宫颈癌，与TNM分类相比，是否存在不足之处？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 如果以现行FIGO分期系统治疗宫颈癌，与TNM分类相比，是否存在不足之处？\n\n<reference text>: 417.Petru, E., et al.Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.Eur J Obstet Gynecol Reprod Biol 143, 69-74 (2009).418.Meva, J., et al.Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "当前的FIGO分期系统在治疗宫颈癌时与TNM分类系统相比，确实存在一些不足之处。虽然FIGO分期系统在全球范围内广泛应用，其主要功能是通过临床检查确定癌症的范围和进展。然而，TNM分类能够通过更详细的肿瘤、淋巴结和转移的评估，提供更确切和精确的癌症分期。这意味着在某些情况下，使用TNM分类可能会更有助于制定更个性化的治疗方案。\n\n此外，FIGO分期系统在具体的肿瘤大小及其生物学特征的评价方面也存在局限性。因此，在处理复杂病例时，尤其是需要精确评估淋巴结状态和远处转移的情况下，结合使用TNM分类系统可能更有优势。\n\n综上所述，虽然FIGO分期系统提供了一种方便的临床工具，但对于某些患者而言，TNM分类可能会提供更全面的信息，从而有助于治疗决策和预后评估。"
}